Hansen Carl L. G.
SEC insider (Form 3/4/5 filer). CIK 0001834412. Chief Executive Officer at AbCellera Biologics Inc. (ABCL). 4 reported Form 4/5 transactions since Sep 2024; latest on Jan 1, 2026. Located in VANCOUVER, A1.
Companies Hansen Carl L. G. has filed insider reports for
- AbCellera Biologics Inc. (ABCL): Director, Officer, 10% Owner, Chief Executive Officer
Hansen Carl L. G.
CIK: 0001834412
Transaction Breakdown
Open Market Buys (P)0 (0.0%)
High conviction signal
Open Market Sales (S)0 (0.0%)
Position reduction
Option Exercises (M)2 (50.0%)
Derivative conversions
Awards (A)2 (50.0%)
Compensation grants
Other (G, F, J, C, D, …)0 (0.0%)
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Companies & Roles (1)
ABCL
AbCellera Biologics Inc.
DirectorOfficer10% Owner
Discretionary Trading P&L
Holdings
Transaction History (4 total)
- Jan 1, 2026ABCL
AbCellera Biologics Inc.
AwardDirectShare option (right to buy)
2.1M shares- - Jan 1, 2025ABCL
AbCellera Biologics Inc.
AwardDirectShare option (right to buy)
2.7M shares- - Nov 25, 2024ABCL
AbCellera Biologics Inc.
ExerciseDirect56.1K shares at avg. $2.70$152K - Sep 20, 2024ABCL
AbCellera Biologics Inc.
ExerciseDirect56.1K shares at avg. $2.70$152K
| Type | Shares | Price | Ownership | |||
|---|---|---|---|---|---|---|
| Jan 1, 2026 | ABCL AbCellera Biologics Inc. | Award Share option (right to buy) | 2,106,505 | - | - | Direct |
| Jan 1, 2025 | ABCL AbCellera Biologics Inc. | Award Share option (right to buy) | 2,730,109 | - | - | Direct |
| Nov 25, 2024 | ABCL AbCellera Biologics Inc. | Exercise | 56,125 | $2.70 | $151,538 | Direct |
| Sep 20, 2024 | ABCL AbCellera Biologics Inc. | Exercise | 56,125 | $2.70 | $151,538 | Direct |
1-4 of 4 transactions